Metastatic Triple-Negative Breast Cancer

Welcome to the Metastatic Triple-Negative Breast Cancer Resource Center! Our goal is to provide current information, news, literature, and other resources in this important area of oncology for you and your patients. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.

Jacquelyn Lauria, RN, APN, AOCNP
Rutgers Cancer Institute of New Jersey

The Landscape of Targeted Therapies in TNBC

Update on Triple-Negative Breast Cancer Disparities for the United States: A Population-Based Study From the United States Cancer Statistics Database, 2010 Through 2014

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.

Metastatic Triple-Negative Breast Cancer Resource Center

Interview with Valerie Shander, MSN, BSN, FNP, RN, AOCNP, CGRA: Brain Metastases and the APPs Role in Managing it

The Landscape of Targeted Therapies in TNBC

Update on Triple-Negative Breast Cancer Disparities for the United States: A Population-Based Study From the United States Cancer Statistics Database, 2010 Through 2014

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.

Triple Negative Breast Cancer Molecular Subtyping and Treatment Progress

NCCN Guidelines for Patients: Breast Cancer - Invasive

Drug discovery today

Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options

Journal of Clinical Medicine

Current therapeutic strategies for metastatic triple-negative breast cancer: From pharmacists’ perspective

ASCO 2023, Journal of Clinical Oncology

The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction

Oncologist

Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in locally advanced or metastatic breast cancer: Prospective cohort study

European Journal of Cancer

Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort

Breast Cancer Research and Treatment

Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer

Critical Reviews in Oncology/Hematology

Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey

Breast Cancer: Basic and Clinical Research

Implementation of risk-stratified breast cancer prevention with a polygenic risk score test in clinical practice

The ASCO Post

Current management of and future possibilities for triple negative breast cancer

Breast Cancer: Basic and Clinical Research

Real-world survival and treatment regimens across first- to third-line treatment for advanced triple-negative breast cancer

Treatment of a Patient With AML and mTNBC

Patient With Lung Metastasis and HER2-Low Status: Evolving Treatment Options

Fast Facts #6: Immunotherapy and Endocrinopathies